JP2001511821A - 筋萎縮性側索硬化症の治療のための免疫調節活性を有する物質の使用 - Google Patents
筋萎縮性側索硬化症の治療のための免疫調節活性を有する物質の使用Info
- Publication number
- JP2001511821A JP2001511821A JP52959599A JP52959599A JP2001511821A JP 2001511821 A JP2001511821 A JP 2001511821A JP 52959599 A JP52959599 A JP 52959599A JP 52959599 A JP52959599 A JP 52959599A JP 2001511821 A JP2001511821 A JP 2001511821A
- Authority
- JP
- Japan
- Prior art keywords
- receptors
- receptor
- als
- immunoglobulins
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.筋萎縮性側索硬化症(ALS)を治療するための、 −Fcγ受容体、好ましくはFcγIII受容体に結合し、 −該受容体又は該受容体ファミリーの各分子種を不活化し、又は前記受容体 を含有する細胞型を破壊せしめ、及び/又は −他の細胞傷害性物質に結合する 抗体、好ましくはモノクローナル抗体、又は −免疫グロブリン、好ましくはサブクラス1(IgG1)及び/又は3(IgG3)に結合す る可溶性Fcγ受容体、好ましくは可溶性FcγRIII受容体、又は −ガルドネルラ・バジャイナーリスから得られ、免疫グロブリンGに結合する タンパク質V、又は −Fcγ受容体、好ましくはFcyγRIII受容体のmRNA配列に特異的に結合するア ンチセンスRNA分子、 又は、それらの調製物の個別に、又は組み合わる使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19723690A DE19723690A1 (de) | 1996-06-05 | 1997-06-05 | Verwendung von Substanzen mit immunmodulatorischer Wirkung für die Behandlung der amyotrophen Lateralsklerose |
PCT/DE1997/002883 WO1999029731A1 (de) | 1997-06-05 | 1997-12-10 | Verwendung von substanzen mit immunmodulatorischer wirkung für die behandlung der amyotrophen lateralsklerose |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001511821A true JP2001511821A (ja) | 2001-08-14 |
Family
ID=25962943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52959599A Ceased JP2001511821A (ja) | 1997-06-05 | 1997-12-10 | 筋萎縮性側索硬化症の治療のための免疫調節活性を有する物質の使用 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0951481B1 (ja) |
JP (1) | JP2001511821A (ja) |
AT (1) | ATE283290T1 (ja) |
DK (1) | DK0951481T3 (ja) |
ES (1) | ES2234038T3 (ja) |
PT (1) | PT951481E (ja) |
WO (1) | WO1999029731A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030126B2 (en) | 2001-11-16 | 2006-04-18 | Als Therapy Development Foundation, Inc. | Use of polyamine analogs for amyotrophic lateral sclerosis |
EP3170899B1 (en) | 2011-10-11 | 2020-06-24 | The Brigham and Women's Hospital, Inc. | Microrna mir-155 in neurodegenerative disorders |
DE102016103562A1 (de) * | 2015-09-17 | 2017-03-23 | Topos Nomos Ltd. | Pharmazeutische Wirkstoffe zur Verwendung in der Behandlung von Amyotropher Lateralsklerose (ALS) und Diagnoseverfahren |
DE102016106510A1 (de) * | 2016-04-08 | 2017-10-12 | ToposNomos Ltd. | Verfahren und Vorrichtung zum extrakorporalen Entfernen von pathogenen und/oder überzähligen Bestandteilen aus einer Zellprobe eines Patienten |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655269B1 (fr) * | 1989-12-01 | 1994-02-11 | Curie Universite Pierre Marie | Proteines empechant l'interaction entre un fragment fc d'une immunoglobuline et son recepteur et utilisation en therapeutique, notamment dans le traitement des affections liees aux virus hiv. |
FR2702481B1 (fr) * | 1993-03-09 | 1995-04-28 | Roussel Uclaf | Nouveaux récepteurs Fc-gamma III humains solubles, leur procédé de préparation, les compositions pharmaceutiques les contenant, leur application comme médicaments et leur application diagnostique. |
DE19723690A1 (de) * | 1996-06-05 | 1998-03-26 | Schubert Walter Dr Md | Verwendung von Substanzen mit immunmodulatorischer Wirkung für die Behandlung der amyotrophen Lateralsklerose |
-
1997
- 1997-12-10 ES ES97951843T patent/ES2234038T3/es not_active Expired - Lifetime
- 1997-12-10 JP JP52959599A patent/JP2001511821A/ja not_active Ceased
- 1997-12-10 AT AT97951843T patent/ATE283290T1/de not_active IP Right Cessation
- 1997-12-10 DK DK97951843T patent/DK0951481T3/da active
- 1997-12-10 EP EP97951843A patent/EP0951481B1/de not_active Expired - Lifetime
- 1997-12-10 PT PT97951843T patent/PT951481E/pt unknown
- 1997-12-10 WO PCT/DE1997/002883 patent/WO1999029731A1/de active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0951481B1 (de) | 2004-11-24 |
ATE283290T1 (de) | 2004-12-15 |
ES2234038T3 (es) | 2005-06-16 |
WO1999029731A1 (de) | 1999-06-17 |
EP0951481A1 (de) | 1999-10-27 |
DK0951481T3 (da) | 2005-03-21 |
PT951481E (pt) | 2005-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6649165B2 (en) | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using soluble FcγRIII receptors | |
Bieber et al. | Human antibodies accelerate the rate of remyelination following lysolecithin‐induced demyelination in mice | |
Levi et al. | Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits | |
Hellström et al. | Specific blocking factors—are they important? | |
Wang et al. | CD200–CD200R regulation of microglia activation in the pathogenesis of Parkinson’s disease | |
KR100493482B1 (ko) | T세포매개된자가면역질환의치료방법 | |
Oehmichen et al. | Neuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after chronic intravenous drug abuse | |
Daëron et al. | Mast cell membrane antigens and Fc receptors in anaphylaxis: II. Functionally distinct receptors for IgG and for IgE on mouse mast cells | |
JP2001511121A (ja) | コポリマー1の摂取又は吸入を通じての多発性硬化症の治療 | |
JP4053596B2 (ja) | 抗体の産生、及び抗体を含む医療的使用 | |
US5189014A (en) | Method of treating cellular Fc receptor mediated hypersensitivity immune disorders | |
US6638506B1 (en) | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to FcγRIII | |
JP3558347B2 (ja) | 自己免疫疾患、とくに多発性硬化症の診断および治療における使用のためのアルファbクリスタリン | |
HUT62486A (en) | Process for producing pharmaceutical compositions comprising antigene-antibody complexes | |
JP2001511821A (ja) | 筋萎縮性側索硬化症の治療のための免疫調節活性を有する物質の使用 | |
US20020115614A1 (en) | Inhibition of complement action | |
EP2049570B1 (en) | Purification of a bivalently active antibody using a non-chromatographic method | |
JPH10505356A (ja) | ヒトへの投与のための組成物および方法、抗原特異的免疫応答のダウンレギュレーションを行うことが可能なペプチド | |
WO2011031676A2 (en) | Depleting immunosuppressive monocytes within a mammal | |
JPH10506877A (ja) | ライグラス花粉アレルゲンのt細胞エピトープ | |
EP0723553A1 (en) | Compounds useful in anti-allergy treatment | |
DE19723690A1 (de) | Verwendung von Substanzen mit immunmodulatorischer Wirkung für die Behandlung der amyotrophen Lateralsklerose | |
Pesce et al. | Modulation of the immune response to allergens: phospholipase A degradation products suppress IgG and IgE response in mice | |
CA2454345A1 (en) | Anti-tumor activity from reptile serum | |
Rolland et al. | Anti-lymphocyte serum: a review of its immunological effects and therapeutic value |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041207 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050304 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080108 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080610 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080722 |